Retatrutide, by Soma, represents a promising breakthrough in weight management . This dual-action medication combines incretin receptor agonist properties with GIP receptor stimulation , indicating substantial results in clinical findings for weight loss . Scientists believe this treatment may provide a different pathway for individuals facing weig